In 2023, David C. Francisco earned $665.51K in total compensation at Organogenesis Holdings Inc., including $419.93K salary, $160.90K bonus and $37.00K in stock. Most recently acquired 330,312 shares in Feb 2025. Currently holds stock worth $2.65M. 4+ years at the helm of Organogenesis Holdings Inc..
Compensation History
Annual executive compensation data for David C. Francisco, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$665.51K
Salary
$419.93K
Bonus
$160.90K
Other
$47.69K
Salary
$419.93KBoard Justification
The compensation philosophy aims to align executive compensation with business objectives, individual performance, and stockholder interests, ensuring competitive compensation to attract and retain top talent.
Bonus
$160.90KBoard Justification
The cash bonus for fiscal year 2023 was based on the achievement of corporate performance metrics, with a target percentage of 60% of base salary, resulting in a payment of approximately 65% of the target bonus.
Other Compensation
$47.69KBoard Justification
Other compensation includes benefits such as a leased automobile, tax gross-ups, life insurance, long-term disability insurance, and 401(k) contributions.
Restricted Stock
Board Justification
The stock awards that vested in 2023 were based on prior grants, with a total of 12,829 shares vesting during the year.
Performance Metrics
The performance metrics for determining the compensation included net revenue, gross margin percentage, and Adjusted EBITDA.
David C. Francisco
CEO of Organogenesis Holdings Inc.
Education
M.B.A. in Finance from Bentley College
Field of Expertise
Finance & Banking - Finance
Sector of Economy
Healthcare
Born
April 1, 1964 - 61 years ago
CEO of Organogenesis Holdings Inc. for
4 years 9 months (Feb 2021 - Present)
Previous Experience
Chief Financial Officer of Organogenesis Holdings Inc.
Other Organogenesis Holdings Inc. CEOs
Holdings
Track David C. Francisco's stock holdings and portfolio value over time.
Insider Trading
David C. Francisco's recent stock transactions, purchases, and sales filed with the SEC.
330,312 shares
ORGO
Feb 19, 2025
Received
160,350 shares
ORGO
Feb 21, 2024
Received
242,508 shares
ORGO
Feb 22, 2023
Received
40,348 shares
ORGO
Feb 15, 2022
Received
10,965 shares
ORGO
Feb 16, 2021
Received
5,396 shares
ORGO
Feb 15, 2021
Received
Rivals
Compare David C. Francisco with competitor CEOs and industry peers.